http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012158613-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2caaba601fd6460c7b37706d920d42e2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
filingDate 2012-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf64cd0a938b9ec2b102b2e820aa98e
publicationDate 2012-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012158613-A
titleOfInvention Stabilized prostaglandin composition
abstract PROBLEM TO BE SOLVED: To provide a PGE 1 preparation exhibiting an increase in stability compared to unformulated misoprostol, particularly a solid state misoprostol preparation having increased storage stability at room temperature. A pharmaceutical delivery device such as a suppository or pessary consisting of a synthetic prostaglandin PGE 1 analog (eg, misoprostol) in a solid polyurethane hydrogel. Polyurethane is either linear or cross-linked. [Selection figure] None
priorityDate 2004-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5047793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004029125-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18934410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4183806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415861636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419641868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420096162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452064535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426021050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419778027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425772305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410534376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82184

Total number of triples: 55.